Survivor Videos
464 articles
Taking a Look At FAK Inhibitors
Dr. Conan Kinsey is looking at how FAK inhibitors can make immunotherapy more effective in combination with chemotherapy.
Is Pancreatic Cancer Different in Black Patients?
Pancreatic cancer occurs at a higher rate in Black patients. Dr. Howard Crawford leads a study looking at the cancer biology for differences.
The Association of Community Cancer Centers (ACCC) Fights for Equitable Cancer Care
The Association of Community Cancer Centers helps local oncologists access the latest treatment and care information, says Dr. Leigh Boehmer.
ASCO 2023: Pancreatic Cancer Research Update
The pancreatic cancer research reports from ASCO 2023 focused on different chemotherapy combinations, including immunotherapy.
New AI Tool Brings Hope in Quest for Earlier Detection
Can AI help catch pancreatic cancer at an earlier stage? Dr. Michael Rosenthal and others are working on an AI tool to do just that.
Phase II mRNA Vaccine Trial Opens
The mRNA vaccine phase II clinical trial, led by Dr. Vinod Balachandran, has opened at Memorial Sloan Kettering, with other locations soon to come.
Common Anti-Anxiety Medications May Affect Outcomes
Many pancreatic cancer patients take anti-anxiety medications. But what you take may affect how your treatment works, says Dr. Michael Feigin.
Let’s Win in a Spectrum News NY1 Report for Pancreatic Cancer Awareness Month
Cindy Gavin and Dr. Allyson Ocean appeared in a Spectrum News NY1 report on a pancreatic cancer patient, for Pancreatic Cancer Awareness Month.
Progress and Promise—Research in 2023
What advances were made in 2023 for pancreatic cancer treatments? Where is research headed in the coming year?
ASCO GI Symposium Features a Broad Range of Pancreatic Cancer Research
Researchers at ASCO GI 2024 reported on research in health disparities, KRAS and other genetic mutations, and novel treatments.
Chemotherapy Plus Immunotherapy Trial Shows Promise
Dr. Gulam Manji leads a clinical trial that uses two types of immunotherapy to enhance chemotherapy for pancreatic cancer patients.
Enhancing Standard Chemotherapy in Metastatic Pancreatic Cancer
Researchers are testing a new kinase inhibitor as a way to make standard chemotherapy more effective against advanced pancreatic cancer.
Slowing the Growth of One Type of Advanced Neuroendocrine Tumor
Dr. Kelsey Klute explains the advantages of the radiopharmaceutical lutetium Lu 177 dotatate treatment for certain neuroendocrine tumors.
In Safe Hands: Selecting the Right Whipple Surgeon
The Whipple procedure is a complex surgery–how do you find an expert with the vast experience needed for your surgery?
2024 AACR Meeting Update
Some of the highlights of the latest pancreatic cancer research from the 2024 AACR meeting include the mRNA vaccine, and a liquid biopsy.